We have issued pragmatic guidance for the routine and crisis management of patients with asthma and COPD during the UK Covid-19 epidemic.
Can Only Plan Daily - COPD is a serious disease needing the right diagnosis and treatment with the person’s need sitting front and centre.
PCRS advocate a pragmatic approach to the pharmacological management of patients with COPD guided by the predominance of breathlessness and/or exacerbations and the presence or absence of comorbid asthma.
As many as one-in-two healthcare attendances for breathing difficulties in Bradford could be triggered by breaches in daily air pollution limits, new research has uncovered.
Pulmonary rehabilitation (PR) improves quality of life and reduces exacerbations and NICE guidelines recommend that PR should be offered to all patients who consider themselves functionally disabled due to their COPD.
People in places such as Blackpool, Liverpool and Inverclyde are amongst the most likely to be admitted to hospital in an emergency and die from their lung condition in the UK, according to
Image shows a 16 weeks post-conception human fetal lung. The branching airway tree is surrounded by bands of developing smooth muscle (green), which also labels the developing vasculature.
On 9 March 2023, the National Asthma and COPD Audit Programme (NACAP) launched its 2018/20 clinical outcomes summary report.
This issue of Primary Care Respiratory Update takes a look at the past, the present and the future.
This edition sees a focus on antibiotics – a hardy perennial topic that requires regular re-visitation. Whether for respiratory infections or as part of rescue pack use, the practical guidance given, together with the views of patients, aims to support your decision-making in practice.
The one-minute sit to stand test (1-MSTST) has become the test of choice during the pandemic for measuring exercise capacity, both at in-person and virtual appointments due to the inability to conduct robust six minute or incremental / endurance shuttle walk tests (6MWT/ ISWT/ ESWT).
In this article we review the major changes in the 2023 GOLD report as they impact on the initial and ongoing pharmacological management of COPD and consider the implications for primary care in the UK.
This issue of PCRU introduces our latest pragmatic guide on severe asthma which guides you through this process ensuring the right patients end up in the right place with the right care.
The publication of the 2023 GOLD Report Global Strategy for Prevention, Diagnosis and Management of COPD represents a shift in the global recommendations for how we should view, categorize and ultimately treat chron